Skip to main content

Table 2 Univariate analysis of PFS in 73 patients with LS-SCLC treated with early CCRT

From: Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities

Variable

Univariate analysis

Relative risk

95% CI

P value

Sex, male

1.37

0.69–3.02

0.3983

Age, ≥ 70 years

0.80

0.39–1.53

0.5190

ECOG-PS = 0

0.81

0.45–1.48

0.4867

Clinical stage III

1.22

0.61–2.69

0.5967

Pre-existing ILAs

1.55

0.67–3.16

0.2579

  1. PFS, progression-free survival; LS-SCLC, limited-stage small-cell lung cancer; CCRT, concurrent chemoradiotherapy; CI, confidence interval; ECOG-PS, Eastern Cooperative Oncology Group performance status; ILA, interstitial lung abnormality
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us